Guidance and regulation

  1. Zika virus: country specific risk
  2. Managing common infections: guidance for primary care
  3. Medicines: packaging, labelling and patient information leaflets
  4. Good pharmacovigilance practice (GPvP)
  5. MHRA fees
See more guidance and regulation in this topic

News and communications

  1. Tapentadol (Palexia): risk of seizures and reports of serotonin syndrome when co-administered with other medicines
  2. Ipilimumab (Yervoy): reports of cytomegalovirus (CMV) gastrointestinal infection or reactivation
  3. Yellow Card App: download the updated App to receive the latest MHRA safety news and report suspected side effects, including in pregnancy
  4. Letters and drug alerts sent to healthcare professionals in December 2018
See more news and communications in this topic

Policy papers and consultations

  1. Reclassification of Otrivine extra dual relief nasal spray solution (ARM 90)
See more policy papers and consultations in this topic